Security key
50127T109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 4,353,765
- Total 13F value
- $46,374,342
- Share change
- -353,749
- SEC-reported price per share
- $10.71
- Number of holders
- 51
- Value change
- -$3,834,134
- Number of buys
- 28
- Number of sells
- 21
- Shares outstanding
- 88,863,281
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
51
Top holders
10
KURA full security history
Ownership snapshot
Full 13F holder table
Kura Oncology, Inc. SEC filings
Kura Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 50127T109
Recent filing periods:
Ownership snapshot
Top reported holders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BIOTECHNOLOGY VALUE FUND L P
Disclosed value leader
BlackRock, Inc.
Comparable rows
8/15
Latest evidence
30 Jun 2026
13D/G
13F
Lead comparable stake: 10%
7 rows are not safely comparable across share classes.
13D/G row: BIOTECHNOLOGY VALUE FUND L P
Showing 1-6 of 15 holder rows.
Quick read
BIOTECHNOLOGY VALUE FUND L P leads the comparable SEC ownership view at 10%.
8 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BIOTECHNOLOGY VALUE FUND L P's linked filing trail.
Comparable ownership
Top 5
BIOTECHNOLOGY VALUE FUND L P
10%
MONTANOVA CAPITAL, LLC
9.7%
BlackRock, Inc.
8.9%
STATE STREET CORP
5.7%
VANGUARD CAPITAL MANAGEMENT LLC
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
10%
Reported 13D/G
· 30 Sep 2025
|
$76,791,609
8,677,018 shares
|
+$24,465,506 | 30 Sep 2025 |
| MONTANOVA CAPITAL, LLC |
13D/G
13F
Company
|
9.7%
Reported 13D/G
· 30 Jun 2026
|
$103,591,098
8,575,422 shares
|
+$12,254,218 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
8.9%
Reported 13D/G
· 30 Sep 2026
|
$115,286,283
10,509,233 shares
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
5.7%
Reported 13D/G
· 31 Dec 2025
|
$58,461,412
5,329,208 shares
|
— | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
5%
Reported 13D/G
· 31 Mar 2026
|
$42,960,319
3,916,164 shares
|
— | 30 Jun 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
4.9%
Reported 13D/G
· 31 Mar 2025
|
$26,070,011
4,004,610 shares
|
$0 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
51
Shares
4,353,765
Rows available
51
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
219
Q3 2026 holders
51
Holder diff
-168
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend